These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18930993)

  • 21. Assessments in ankylosing spondylitis.
    Zochling J; Braun J
    Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):699-712. PubMed ID: 17678831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissemination and evaluation of the European League Against Rheumatism recommendations for the role of the nurse in the management of chronic inflammatory arthritis: results of a multinational survey among nurses, rheumatologists and patients.
    van Eijk-Hustings Y; Ndosi M; Buss B; Fayet F; Moretti A; Ryan S; Savel C; Scholte-Voshaar M; de la Torre-Aboki J; van Tubergen A
    Rheumatology (Oxford); 2014 Aug; 53(8):1491-6. PubMed ID: 24692574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
    van Eijk-Hustings Y; van Tubergen A; Boström C; Braychenko E; Buss B; Felix J; Firth J; Hammond A; Harston B; Hernandez C; Huzjak M; Korandová J; Kukkurainen ML; Landewé R; Mezieres M; Milincovic M; Moretti A; Oliver S; Primdahl J; Scholte-Voshaar M; de la Torre-Aboki J; Waite-Jones J; Westhovens R; Zangi HA; Heiberg T; Hill J;
    Ann Rheum Dis; 2012 Jan; 71(1):13-9. PubMed ID: 22039168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EULAR recommendations for the management of large vessel vasculitis.
    Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
    Ann Rheum Dis; 2009 Mar; 68(3):318-23. PubMed ID: 18413441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dissemination and evaluation of ASAS/EULAR recommendations for the management of ankylosing spondylitis in Europe].
    Braun J; Sieper J
    Z Rheumatol; 2009 Jul; 68(5):417-9. PubMed ID: 19449018
    [No Abstract]   [Full Text] [Related]  

  • 26. The German version of the Toronto Structured Interview for Alexithymia: factor structure, reliability, and concurrent validity in a psychiatric patient sample.
    Grabe HJ; Löbel S; Dittrich D; Bagby RM; Taylor GJ; Quilty LC; Spitzer C; Barnow S; Mathier F; Jenewein J; Freyberger HJ; Rufer M
    Compr Psychiatry; 2009; 50(5):424-30. PubMed ID: 19683612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
    Maksymowych WP; Fitzgerald O; Wells GA; Gladman DD; Landewé R; Ostergaard M; Taylor WJ; Christensen R; Tak PP; Boers M; Syversen SW; Bathon JM; Ritchlin CJ; Mease PJ; Bykerk VP; Garnero P; Geusens P; El-Gabalawy H; Aletaha D; Inman RD; Kraus VB; Kvien TK; van der Heijde D
    J Rheumatol; 2009 Aug; 36(8):1792-9. PubMed ID: 19671814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.
    van der Heijde D; Lie E; Kvien TK; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R;
    Ann Rheum Dis; 2009 Dec; 68(12):1811-8. PubMed ID: 19060001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
    Avouac J; Kowal-Bielecka O; Landewe R; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality indicators, guidelines and outcome measures in ankylosing spondylitis.
    Zochling J; Braun J
    Clin Exp Rheumatol; 2007; 25(6 Suppl 47):147-52. PubMed ID: 18021521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [German translation and cross-cultural adaptation of the ASAS health index : An ICF-based instrument for documentation of functional ability in patients with ankylosing spondylitis].
    Kiltz U; Winter J; Schirmer M; Weber U; Hammel L; Baraliakos X; Braun J
    Z Rheumatol; 2016 Dec; 75(10):993-998. PubMed ID: 27785609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EULAR recommendations for the management of primary small and medium vessel vasculitis.
    Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
    Ann Rheum Dis; 2009 Mar; 68(3):310-7. PubMed ID: 18413444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canadian recommendations for the management of spondyloarthritis address many different levels of patient care.
    Braun J
    Nat Clin Pract Rheumatol; 2008 May; 4(5):234-5. PubMed ID: 18334982
    [No Abstract]   [Full Text] [Related]  

  • 34. [ASAS recommendations on the use of TNF inhibitors for patients with axial spondyloarthritis : evaluation of the 2010 update in the German-speaking area].
    Kiltz U; Sieper J; Braun J
    Z Rheumatol; 2013 Feb; 72(1):81-8. PubMed ID: 23338704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding.
    Fraser IS; Critchley HO; Munro MG; Broder M;
    Fertil Steril; 2007 Mar; 87(3):466-76. PubMed ID: 17362717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?
    van der Heijde D; Braun J; Landewé R; Davis J; Sieper J; van der Linden S; Dougados M
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii108-9. PubMed ID: 15708922
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating rheumatoid arthritis to target: the patient version of the international recommendations.
    de Wit MP; Smolen JS; Gossec L; van der Heijde DM
    Ann Rheum Dis; 2011 Jun; 70(6):891-5. PubMed ID: 21478190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
    Song IH; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.